|Articles|December 1, 1998

New Developments in the Treatment of Hypertension: What the HOT Study Means to JNC-VI
Volume 4
Issue 13 Suppl

Hypertension in the Older Patient

Author(s)Gary Gerstenblith, MD

Download PDF: Hypertension in the Older Patient

Articles in this issue

almost 28 years ago

Article

Participating Faculty

almost 28 years ago

Article

Introduction

almost 28 years ago

Article

The Hypertension Optimal Treatment (HOT) Study: Implications for Hypertension Management and the J-Shape Curve

almost 28 years ago

Article

Barriers to Guideline Adherence

almost 28 years ago

Article

Hypertension in Managed Care

almost 28 years ago

Article

Beta Blockers as First-Line Therapy for Hypertension in the Elderly

almost 28 years ago

Article

Cost Effectiveness of Intensive Treatment of Hypertension

almost 28 years ago

Article

Selected Abstracts

almost 28 years ago

Article

CME Quiz

almost 28 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Hypertension in the Older Patient

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials

Bringing CAR T-Cell Therapy Into Community Cancer Centers

The True Cost of Running a Community CAR T-Cell Program

Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI

FDA Approves First Disease-Modifying Treatment for AxD